Ya Chen Tina Shih, Ph.D.

Peer-Reviewed Articles

1. Huey RW, George GC, Phillips P, White R, Fu S, Janku F, Karp DD, Naing A, Piha-Paul S, Subbiah V, Tsimberidou AM, Pant S, Yap TA, Rodon J, Meric-Bernstam F, Shih YCT, Hong DS. Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials. Oncologist 26(7):588-596, 2021. e-Pub 2021. PMID: 33783054.
2. Halpern MT, Shih YT, Yabroff KR, Ekwueme DU, Bradley CJ, Davidoff AJ, Sabik LM, Lipscomb J. A framework for cancer health economics research. Cancer 127(7):994-996, 2021. e-Pub 2020. PMID: 33237590.
3. Chen AB, Niu J, Cronin AM, Shih YT, Giordano S, Schrag D. Variation in Use of High-Cost Technologies for Palliative Radiation Therapy by Radiation Oncologists. J Natl Compr Canc Netw 19(4):1-11, 2021. e-Pub 2021. PMID: 33578375.
4. Bradley CJ, Yabroff KR, Zafar SY, Shih YCT. Time to add screening for financial hardship as a quality measure?. CA Cancer J Clin 71(2):100-106, 2021. e-Pub 2020. PMID: 33226648.
5. Lopez-Olivo MA, Minnix JA, Fox JG, Nishi SPE, Lowenstein LM, Maki KG, Leal VB, Shih YCT, Cinciripini PM, Volk RJ. Smoking cessation and shared decision-making practices about lung cancer screening among primary care providers. Cancer Med 10(4):1357-1365, 2021. e-Pub 2021. PMID: 33463091.
6. Shih YCT, Dong W, Xu Y, Etzioni R, Shen Y. Incorporating Baseline Breast Density When Screening Women at Average Risk for Breast Cancer : A Cost-Effectiveness Analysis. Ann Intern Med. e-Pub 2021. PMID: 33556275.
7. Shih YCT, Kim B, Halpern MT. State of Physician and Pharmacist Oncology Workforce in the United States in 2019. JCO Oncol Pract 17(1):OP2000600, 2021. e-Pub 2020. PMID: 33270520.
8. Shih YCT, Xu Y, Lowenstein LM, Volk RJ. Implementation of Shared Decision Making for Lung Cancer Screening Among the Privately Insured Nonelderly. MDM Policy Pract 6(1):2381468320984773, 2021. e-Pub 2021. PMID: 33598545.
9. Zhao H, Xu Y, Huo J, Burks AC, Ost DE, Shih YCT. Updated Analysis of Complication Rates Associated With Invasive Diagnostic Procedures After Lung Cancer Screening. JAMA Netw Open 3(12):e2029874, 2020. e-Pub 2020. PMID: 33326023.
10. Etzioni R, Shen Y, Shih YCT. Identifying Preferred Breast Cancer Risk Predictors: A Holistic Perspective. J Natl Cancer Inst. e-Pub 2020. PMID: 33301010.
11. Pan IW, Yen TWF, Huo J, Chen C, Smith BD, Shih YCT. Choice of local therapy for young women with early-stage breast cancer who have young-aged children. Cancer 126(21):4761-4769, 2020. e-Pub 2020. PMID: 32757314.
12. Asaad M, Xu Y, Chu CK, Shih YCT, Mericli AF. The impact of co-surgeons on complication rates and healthcare cost in patients undergoing microsurgical breast reconstruction: analysis of 8680 patients. Breast Cancer Res Treat 184(2):345-356, 2020. e-Pub 2020. PMID: 32803638.
13. Lopez-Olivo MA, Maki KG, Choi NJ, Hoffman RM, Shih YCT, Lowenstein LM, Hicklen RS, Volk RJ. Patient Adherence to Screening for Lung Cancer in the US: A Systematic Review and Meta-analysis. JAMA Netw Open 3(11):e2025102, 2020. e-Pub 2020. PMID: 33196807.
14. Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih YCT, Walter LC, Kim JJ, Andrews KS, DeSantis CE, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC, Smith RA. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin 70(5):321-346, 2020. e-Pub 2020. PMID: 32729638.
15. Tang C, Lei X, Smith GL, Pan HY, Hess K, Chen A, Hoffman KE, Chapin BF, Kuban DA, Anscher M, Shih YCT, Frank SJ, Smith BD. Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data. Pract Radiat Oncol 10(4):282-292, 2020. e-Pub 2020. PMID: 32298794.
16. Shih YCT, Shen Y. Time to Consider a Personalized Approach to Incorporate Tomosynthesis into Routine Breast Cancer Screening. J Natl Cancer Inst 112(6):553-554, 2020. e-Pub 2019. PMID: 31503277.
17. Yabroff KR, Bradley C, Shih YT. Understanding Financial Hardship among Cancer Survivors in the United States: Strategies for Prevention and Mitigation. J Clin Oncol 38(4):292-301, 2020. e-Pub 2019. PMID: 31804869.
18. Shih YCT, Xu Y, Chien CR, Kim B, Shen Y, Li L, Geynisman DM. Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II-An Updated Analysis of SEER-Medicare Data. Pharmacoeconomics 37(12):1495-1507, 2019. PMID: 31286464.
19. Shen C, Gu D, Zhou S, Xu Y, Sarshekeh AM, Halperin D, Shih YCT|, Yao JC, Dasari A. Racial Differences in the Incidence and Survival of Patients With Neuroendocrine Tumors. Pancreas 48(10):1373-1379, 2019. PMID: 31688604.
20. Shih YCT, Liu L. Use of Claims Data for Cost and Cost-Effectiveness Research. Semin Radiat Oncol 29(4):348-353, 2019. PMID: 31472737.
21. Tak HJ, Chen LW, Wilson FA, Goldsweig AM, Oleynikov D, Hawking M, Shih YCT. Post-Discharge Services for Different Diagnoses Than Index Hospitalization Predict Decreased 30-Day Readmissions Among Medicare Beneficiaries. J Gen Intern Med 34(9):1766-1774, 2019. e-Pub 2019. PMID: 31228052.
22. Ikoma N, Kim B, Elting LS, Shih YCT, Badgwell BD, Mansfield P. Trends in Volume-Outcome Relationship in Gastrectomies in Texas. Ann Surg Oncol 26(9):2694-2702, 2019. e-Pub 2019. PMID: 31264116.
23. Shih YCT, Cortes JE, Kantarjian HM. Treatment value of second-generation BCR-ABL1 tyrosine kinase inhibitors compared with imatinib to achieve treatment-free remission in patients with chronic myeloid leukaemia: a modelling study. Lancet Haematol 6(8):e398-e408, 2019. e-Pub 2019. PMID: 31208943.
24. Milbury K, Li J, Weathers SP, Shih YCT, Malliaha S, Li Y, Cohen L. A research protocol for a pilot, randomized controlled trial designed to examine the feasibility of a dyadic versus individual yoga program for family caregivers of glioma patients undergoing radiotherapy. Pilot Feasibility Stud 5:95, 2019. e-Pub 2019. PMID: 31367462.
25. Huo J, Shih YCT. Complication Rates in a Study of Invasive Diagnostic Procedures for Lung Abnormalities-In Reply. JAMA Intern Med 179(6):847, 2019. PMID: 31157849.
26. Yoon G, Jiang W, Liu L, Shih YCT. Simple Quasi-Bayes Approach for Modeling Mean Medical Costs. Int J Biostat. e-Pub 2019. PMID: 31194679.
27. Fredell MN, Kantarjian HM, Shih YCT, Ho V, Mukherjee B. How Much of US Health-Care Spending Provides Direct Care or Benefit to Patients?. Cancer 125(9):1404-1409, 2019. e-Pub 2019. PMID: 30695098.
28. Hoover DS, Spears CA, Vidrine DJ, Walker JL, Shih YCT, Wetter DW. Smoking Cessation Treatment Needs of Low SES Cervical Cancer Survivors. Am J Health Behav 43(3):606-620, 2019. PMID: 31046890.
29. Logan JK, Jiang J, Shih YCT, Lei X, Xu Y, Hoffman KE, Giordano SH, Smith BD. Trends in Radiation for Bone Metastasis During a Period of Multiple National Quality Improvement Initiatives. J Oncol Pract 15(4):JOP1800588, 2019. e-Pub 2019. PMID: 30849005.
30. Sharma M, Holmes HM, Mehta HB, Chen H, Aparasu RR, Shih YCT, Giordano SH, Johnson ML. The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer. Cancer 125(7):1155-1162, 2019. e-Pub 2019. PMID: 30605231.
31. Chien CR, Geynisman DM, Kim B, Xu Y, Shih YCT. Economic Burden of Renal Cell Carcinoma-Part I: An Updated Review. Pharmacoeconomics 37(3):301-331, 2019. e-Pub 2018. PMID: 30467701.
32. Huo J, Xu Y, Sheu T, Volk RJ, Shih YCT. Complication Rates and Downstream Medical Costs Associated with Invasive Diagnostic Procedures for Lung Abnormalities in the Community Setting. JAMA Intern Med 179(3):324-332, 2019. e-Pub 2019. PMID: 30640382.
33. Hwang JP, Huang D, Vierling JM, Suarez-Almazor ME, Shih YCT, Chavez-MacGregor M, Duan Z, Giordano SH, Hershman DL, Fisch MJ, Cantor SB. Cost-effectiveness analysis of hepatitis B virus screening and management in patients with hematologic or solid malignancies anticipating immunosuppressive cancer therapy. JCO Clin Cancer Inform 3:1-12, 2019. PMID: 30892921.
34. Spivey CA, Qiao Y, Wang J, Shih YCT, Wan JY, Dagogo-Jack S, Cushman WC, Hines LE, Chisholm-Burns MA. Comparative Effectiveness of Medication Therapy Management Eligibility Criteria across Racial/Ethnic Groups. J Am Geriatr Soc 67(3):581-587, 2019. e-Pub 2019. PMID: 30674080.
35. Cunningham SA, Yu R, Shih YCT, Giordano S, McNeill LH, Rechis R, Peterson SK, Cinciripini P, Foxhall L, Hawk E, Shete S. Cancer-Related Risk Perceptions and Beliefs in Texas: Findings from a 2018 Population-Level Survey. Cancer Epidemiol Biomarkers Prev 28(3):486-494, 2019. e-Pub 2019. PMID: 30700446.
36. Huo J, Aloia TA, Xu Y, Chung TH, Sheu T, Shih YCT. Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma. Value Health 22(3):284-292, 2019. e-Pub 2018. PMID: 30832966.
37. Shih YCT, Dong W, Xu Y, Shen Y. Assessing the Cost-Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women. Value Health 22(2):185-193, 2019. e-Pub 2018. PMID: 30711063.
38. Schiman C, Liu L, Shih YCT, Zhao L, Daviglus ML, Liu K, Fries J, Garside DB, Vu TT, Stamler J, Lloyd-Jones DM, Allen NB. Cardiovascular health in young and middle adulthood and medical care utilization and costs at older age - The Chicago Heart Association Detection Project Industry (CHA). Prev Med 119:87-98, 2019. e-Pub 2018. PMID: 30594534.
39. Liu L, Shih YCT, Strawderman RL, Zhang D, Johnson B, Chai H. Statistical Analysis of Zero-inflated Non-negative Continuous Data: a Review. Statistical Science 34(2):253-279, 2019.
40. Vu TT, Zhao L, Liu L, Schiman C, Lloyd-Jones DM, Daviglus ML, Liu K, Garside DB, Stamler J, Fries JF, Shih YCT, Allen NB. Favorable Cardiovascular Health at Young and Middle Ages and Dementia in Older Age-The CHA Study. J Am Heart Assoc 8(1):e009730, 2019. PMID: 30590968.
41. Pan IW, Lam S, Clarke DF, Shih YCT. Insurance transitions and healthcare utilization for children with refractory epilepsy. Epilepsy Behav 89:48-54, 2018. e-Pub 2018. PMID: 30384099.
42. Qiao Y, Spivey CA, Wang J, Shih YCT, Wan JY, Kuhle J, Dagogo-Jack S, Cushman WC, Chisholm-Burns M. Predictive Value Positive of MTM Eligibility Criteria under MMA and ACA in Identifying Individuals with Medication Utilization Issues. J Pharm Health Serv Res 9(4):393-401, 2018. e-Pub 2018. PMID: 30906425.
43. Altok M, Kim B, Patel BB, Shih YCT, Ward JF, McRae SE, Chapin BF, Pisters LL, Pettaway CA, Kim J, Demirel HC, Davis JW. Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research. Prostate Cancer Prostatic Dis 21(4):524-532, 2018. e-Pub 2018. PMID: 29988098.
44. Shen C, Dasari A, Xu Y, Zhou S, Gu D, Chu Y, Halperin DM, Shih YCT, Yao JC. Pre-existing Symptoms and Healthcare Utilization Prior to Diagnosis of Neuroendocrine Tumors: A SEER-Medicare Database Study. Sci Rep 8(1):16863, 2018. e-Pub 2018. PMID: 30442902.
45. Guo F, Kuo YF, Shih YCT, Giordano SH, Berenson AB. Trends in Breast Cancer Mortality by Stage at Diagnosis Among Young Women in the United States. Cancer 124(17):3500-3509, 2018. e-Pub 2018. PMID: 30189117.
46. Shen C, Dasari A, Gu D, Chu Y, Zhou S, Xu Y, Halperin D, Fu S, Yao JC, Shih YCT. Costs of Cancer Care for Elderly Patients with Neuroendocrine Tumors. Pharmacoeconomics 36(8):1005-1013, 2018. e-Pub 2018. PMID: 29682693.
47. Parseghian CM, Patnana M, Bhosale P, Hess KR, Shih YCT|, Kim B, Kopetz S, Overman MJ, Varadhachary GR, Javle M, Naing A, Piha-Paul S, Hong D, Le H, Subbiah V, Pant S. Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With Immunotherapy. J Immunother 41(6):284-291, 2018. e-Pub 2018. PMID: 29668571.
48. Kim CR, Kim B, Ning MS, Reddy JP, Liao Z, Tang C, Welsh JW, Mott FE, Shih YT, Gomez DR. Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non-Small-Cell Lung Cancer After Definitive Radiation Therapy. Clin Lung Cancer 19(4):e517-e528, 2018. e-Pub 2018. PMID: 29685701.
49. Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte SJ, Etzioni R, McKenna MT, Oeffinger KC, Shih YCT, Walter LC, Andrews KS, Brawley OW, Brooks D, Fedewa SA, Manassaram-Baptiste D, Siegel RL, Wender RC, Smith RA. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 68(4):250-281, 2018. e-Pub 2018. PMID: 29846947.
50. Zhao X, Wang W, Liu L, Shih YCT. A flexible quantile regression model for medical costs with application to Medical Expenditure Panel Survey Study. Stat Med 37(17):2645-2666, 2018. e-Pub 2018. PMID: 29722044.
51. Pan HY, Jiang J, Hoffman KE, Tang C, Choi SL, Nguyen QN, Frank SJ, Anscher MS, Shih YCT, Smith BD. Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer. J Clin Oncol 36(18):JCO2017755371, 2018. e-Pub 2018. PMID: 29561693.
52. Li L, Wu CH, Ning J, Huang X, Shih YCT, Shen Y. Semiparametric Estimation of Longitudinal Medical Cost Trajectory. J Am Stat Assoc 113(522):582-592, 2018. e-Pub 2018. PMID: 30853736.
53. Hwang JP, Ahmed S, Ariza-Heredia EJ, Duan Z, Zhao H, Schmeler KM, Ramondetta L, Parker SL, Suarez-Almazor ME, Ferrajoli A, Shih YCT, Giordano SH, Chiao EY. Low Rate of Cervical Cancer Screening among Women with Hematologic Malignancies after Stem Cell Transplant. Biol Blood Marrow Transplant 24(5):1094-1098, 2018. e-Pub 2018. PMID: 29378304.
54. Ward JC, Levit LA, Page RD, Hennessy JE, Cox JV, Kamin DY, Bruinooge SS, Shih YCT|, Polite BN. Impact on Oncology Practices of Including Drug Costs in Bundled Payments. J Oncol Pract 14(5):JOP1700036, 2018. e-Pub 2018. PMID: 29648923.
55. Huo J, Yang M, Shih YCT. Sensitivity of Claims-Based Algorithms to Ascertain Smoking Status More Than Doubled with Meaningful Use. Value Health 21(3):334-340, 2018. e-Pub 2017. PMID: 29566841.
56. Shih YCT, Nasso SF, Zafar SY. Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care. Pharmacoeconomics 36(3):259-261, 2018. e-Pub 2018. PMID: 29396743.
57. Spivey CA, Wang J, Qiao Y, Shih YCT, Wan JY, Kuhle J, Dagogo-Jack S, Cushman WC, Chisholm-Burns M. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act. J Manag Care Spec Pharm 24(2):97-107, 2018. PMID: 29384031.
58. Smieliauskas F, Sharma H, Hurley C, de Souza JA, Shih YCT. State insurance mandates and off-label use of chemotherapy. Health Econ 27(1):e55-e70, 2018. e-Pub 2017. PMID: 28726348.
59. Shen C, Zhao B, Liu L, Shih YCT. Adherence to tyrosine kinase inhibitors among Medicare Part D beneficiaries with chronic myeloid leukemia. Cancer 124(2):364-373, 2018. e-Pub 2017. PMID: 28976559.
60. Chaoul A, Milbury K, Spelman A, Basen-Engquist K, Hall MH, Wei Q, Shih YCT, Arun B, Valero V, Perkins GH, Babiera GV, Wangyal T, Engle R, Harrison CA, Li Y, Cohen L. Randomized trial of Tibetan yoga in patients with breast cancer undergoing chemotherapy. Cancer Cytopathol 124(1):36-45, 2018. e-Pub 2017. PMID: 28940301.
61. Qiao Y, Spivey CA, Wang J, Shih YCT, Wan JY, Kuhle J, Dagogo-Jack S, Cushman WC, Chisholm-Burns MA. Higher Predictive Value Positive for MMA Than ACA MTM Eligibility Criteria Among Racial and Ethnic Minorities: An Observational Study. Inquiry 55:46958018795749, 2018. PMID: 30175638.
62. Shen C, Chu Y, Halperin DM, Dasari A, Zhou S, Xu Y, Yao JC, Shih YCT. Carcinoid Syndrome and Costs of Care During the First Year After Diagnosis of Neuroendocrine Tumors Among Elderly Patients. Oncologist 22(12):1451-1462, 2017. e-Pub 2017. PMID: 28642335.
63. Shih YCT, Shen C, Hu JC. Do Robotic Surgical Systems Improve Profit Margins? A Cross-Sectional Analysis of California Hospitals. Value Health 20(8):1221-1225, 2017. e-Pub 2017. PMID: 28964456.
64. Shih YCT, Xu Y, Liu L, Smieliauskas F. Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries. J Clin Oncol 35(22):2482-2489, 2017. e-Pub 2017. PMID: 28471711.
65. Goto D, Shih YCT, Lecomte P, Olson M, Udeze C, Park Y, Mullins CD. Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis. Pharmacoeconomics 35(7):685-695, 2017. PMID: 28378193.
66. Shih YCT, Xu Y, Chavez-MacGregor M, Guadagnolo BA, Smith BD, Giordano SH. Association Between Quality of Care for Breast Cancer and Health Insurance Exchange Coverage: An Analysis of Use of Radiation Therapy After Breast-Conserving Surgery. JAMA Oncol 3(10):1425-1426. e-Pub 2017. PMID: 28570719.
67. Shih YCT, Chien CR. A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment. Cancer 123(6):928-939, 2017. e-Pub 2016. PMID: 27893929.
68. Allen NB, Zhao L, Liu L, Daviglus M, Liu K, Fries J, Shih YCT, Garside D, Vu TH, Stamler J, Lloyd-Jones DM. Favorable Cardiovascular Health, Compression of Morbidity, and Healthcare Costs: Forty-Year Follow-Up of the CHA Study (Chicago Heart Association Detection Project in Industry). Circulation 135(18):1693-1701, 2017. PMID: 28461414.
69. Halperin DM, Shen C, Dasari A, Xu Y, Chu Y, Zhou S, Shih YCT, Yao JC. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study. Lancet Oncol 18(4):525-534, 2017. e-Pub 2017. PMID: 28238592.
70. Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih YCT, Yao JC. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol 3(10):1335-1342. e-Pub 2017. PMID: 28448665.
71. Pan HY, Jiang J, Shih YCT, Smith BD. Adoption of Radiation Technology Among Privately Insured Nonelderly Patients With Cancer in the United States, 2008 to 2014: A Claims-Based Analysis. J Am Coll Radiol 14(8). e-Pub 2017. PMID: 28408078.
72. Shen C, Dasari A, Chu Y, Halperin DM, Zhou S, Xu Y, Shih YCT, Yao JC. Clinical, pathological and demographic factors associated with development of recurrences after surgical resection in elderly patients with neuroendocrine tumors. Ann Oncol 28(7). e-Pub 2017. PMID: 28444105.
73. Huo J, Shen C, Volk RJ, Shih YCT. Use of CT and Chest Radiography for Lung Cancer Screening Before and After Publication of Screening Guidelines: Intended and Unintended Uptake. JAMA Intern Med 177(3):439-441, 2017. PMID: 28135349.
74. Smith GL, Ganz PA, Bekelman JE, Chmura SJ, Dignam JJ, Efstathiou JA, Jagsi R, Johnstone PA, Steinberg ML, Williams SB, Yu JB, Zietman AL, Weichselbaum RR, Shih YCT. Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop. Int J Radiat Oncol Biol Phys 97(3):450-461, 2017. e-Pub 2016. PMID: 28011046.
75. Reddy JP, Tang C, Shih YCT, Kim B, Kim C, Nguyen QN, Welsh J, Benveniste M, Zhang J, Liao Z, Gomez DR. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer. Clin Lung Cancer 18(2):141-148, 2017. e-Pub 2016. PMID: 27913215.
76. Arun B, Austin T, Babiera GV, Basen-Engquist K, Carmack CL, Chaoul A, Cohen L, Connelly L, Haddad R, Harrison C, Li Y, Mallaiah S, Nagarathna R, Parker PA, Perkins GH, Reuben JM, Shih YCT, Spelman A, Sood A, Yang P, Yeung SJ. A Comprehensive Lifestyle Randomized Clinical Trial: Design and Initial Patient Experience. Integr Cancer Ther 16(1):3-20, 2017. e-Pub 2016. PMID: 27903842.
77. Halpern JA, Shoag JE, Mittal S, Oromendia C, Ballman KV, Hershman DL, Wright JD, Shih YCT, Nguyen PL, Hu JC. Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Arm. J Urol 197(2):363-368, 2017. e-Pub 2016. PMID: 27569432.
78. Halpern JA, Shoag JE, Artis AS, Ballman KV, Sedrakyan A, Hershman DL, Wright JD, Shih YCT, Hu JC. National Trends in Prostate Biopsy and Radical Prostatectomy Volumes Following the United States Preventative Services Task Force Guidelines Against Prostate-Specific Antigen Screening. JAMA Surg 152(2):192-198, 2017. e-Pub 2016. PMID: 27806151.
79. Smith BD, Jiang J, Shih YCT, Giordano SH, Huo J, Jagsi R, Momoh AO, Caudle AS, Hunt KK, Shaitelman SF, Buchholz TA, Shirvani SM. Cost and Complications of Local Therapies for Early-Stage Breast Cancer. J Natl Cancer Inst 109(1), 2017. e-Pub 2016. PMID: 27678203.
80. Shen C, Zhao B, Liu L, Shih YCT. Financial Burden for Patients With Chronic Myeloid Leukemia Enrolled in Medicare Part D Taking Targeted Oral Anticancer Medications. J Oncol Pract 13(2):JOP2016014639. e-Pub 2017. PMID: 28095170.
81. Giordano SH, Niu J, Chavez-MacGregor M, Zhao H, Zorzi D, Shih YCT, Smith BD, Shen C. Estimating regimen-specific costs of chemotherapy for breast cancer: Observational cohort study. Cancer 122(22):3447-3455, 2016. e-Pub 2016. PMID: 27723214.
82. Correa-Fernández V, Díaz-Toro EC, Reitzel LR, Guo L, Chen M, Li Y, Calo WA, Shih YCT, Wetter DW. Combined treatment for at-risk drinking and smoking cessation among Puerto Ricans: A randomized clinical trial. Addict Behav 65:185-192. e-Pub 2016. PMID: 27825036.
83. Saslow D, Andrews KS, Manassaram-Baptiste D, Loomer L, Lam KE, Fisher-Borne M, Smith RA, Fontham ET, American Cancer Society Guideline Development Group (+: Shih YCT is a member of the ACS Guideline Development Group). Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement. CA Cancer J Clin 66(5):375-85, 2016. e-Pub 2016. PMID: 27434803.
84. Huo J, Smith BD, Giordano SH, Reece GP, Shih YCT. A comparison of patient-centered economic and clinical outcomes of post-mastectomy breast reconstruction between obese and non-obese patients. Breast 30:118-124. e-Pub 2016. PMID: 27697676.
85. Huo J, Smith BD, Giordano SH, Reece GP, Shih YCT. Post-mastectomy breast reconstruction and its subsequent complications: a comparison between obese and non-obese women with breast cancer. Breast Cancer Res Treat 157(2):373-83, 2016. e-Pub 2016. PMID: 27178333.
86. Williams SB, Huo J, Chamie K, Hu JC, Giordano SH, Hoffman KE, Dinney CPN, Kamat AM, Shih YCT. Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer. Eur Urol Focus(16):S2405-4569. e-Pub 2016. PMID: 28753760.
87. Chen J, Liu L, Shih YCT, Zhang D, Severini TA. A flexible model for correlated medical costs, with application to medical expenditure panel survey data. Stat Med 35(6):883-94, 2016. e-Pub 2015. PMID: 26403805.
88. Shen C, Xu Y, Dasari A, Shih YCT, Yao JC. Octreotide LAR Dosage and Survival Among Elderly Patients With Distant-Stage Neuroendocrine Tumors. Oncologist 21(3):308-13, 2016. e-Pub 2016. PMID: 26911407.
89. Shen C, Shih YCT. Therapeutic substitutions in the midst of new technology diffusion: The case of treatment for localized prostate cancer. Soc Sci Med 151:110-120, 2016. e-Pub 2016. PMID: 26799678.
90. Shih, YCT, Chien CR, Roguel M, Hernandez M, Hajek RA, Jones LA. Cost-Effectiveness Analysis of a Capitated Patient Navigation Program for Medicare Beneficiaries Diagnosed with Lung Cancer. Health Services Research 51(2):746-67, 2016.
91. Wang J, Qiao Y, Shih YCT, Jarrett-Jamison J, Spivey CA, Wan JY, White-Means SI, Dagogo-Jack S, Cushman WC, Chisholm-Burns M. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups. J Manag Care Spec Pharm 21(11):993-1003, 2015. PMID: 26521111.
92. Shen C, Shih YCT, Xu Y, Yao JC. Octreotide Long-Acting Repeatable among Elderly Patients with Neuroendocrine Tumors: A Survival Analysis of SEER-Medicare Data. Cancer Epidemiol Biomarkers Prev 24(11):1656-65, 2015. e-Pub 2015. PMID: 26315553.
93. Coca Perraillon M, Shih YCT, Thisted RA. Predicting the EQ-5D-3L Preference Index from the SF-12 Health Survey in a National US Sample: A Finite Mixture Approach. Med Decis Making 35(7):888-901, 2015. e-Pub 2015. PMID: 25840902.
94. Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YCT, Walter LC, Church TR, Flowers CR, LaMonte SJ, Wolf AM, DeSantis C, Lortet-Tieulent J, Andrews K, Manassaram-Baptiste D, Saslow D, Smith RA, Brawley OW, Wender R. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA 314(15):1599-614, 2015. PMID: 26501536.
95. Ning J, Peng S, Ueno N, Xu Y, Shih YCT, Karuturi M, Giordano S, Shen Y. Has racial difference in cause-specific death improved in older patients with late-stage breast cancer?. Ann Oncol 26(10):2161-8, 2015. e-Pub 2015. PMID: 26223248.
96. Guadagnolo BA, Liao KP, Giordano SH, Elting LS, Shih YCT. Variation in Intensity and Costs of Care by Payer and Race for Patients Dying of Cancer in Texas: An Analysis of Registry-linked Medicaid, Medicare, and Dually Eligible Claims Data. Med Care 53(7):591-8, 2015. PMID: 26067883.
97. Wang J, Shih YCT, Qin Y, Young T, Thomas Z, Spivey CA, Solomon DK, Chisholm-Burns M. Trends in Medicare Part D Medication Therapy Management Eligibility Criteria. Am Health Drug Benefits 8(5):247-55, 2015. PMID: 26380030.
98. Shih YCT, Smieliauskas F, Geynisman DM, Kelly RJ, Smith TJ. Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011. J Clin Oncol 33(19):2190-6, 2015. e-Pub 2015. PMID: 25987701.
99. Tak H, Ruhnke GW, Shih YCT. The Association between Patient-Centered Attributes of Care and Patient Satisfaction. Patient 8(2):187-97, 2015. e-Pub 2014. PMID: 25011683.
100. Sehdev A, Shih YCT, Vekhter B, Bissonnette MB, Olopade OI, Polite BN. Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population. Cancer 121(7):1071-8, 2015. e-Pub 2014. PMID: 25424411.
101. Geynisman DM, Hu JC, Liu L, Shih YCT. Treatment patterns and costs for metastatic renal cell carcinoma patients with private insurance in the United States. Clin Genitourin Cancer 13(2):e93-100, 2015. e-Pub 2014. PMID: 25450038.
102. Smieliauskas F, MacMahon H, Salgia R, Shih YCT. Geographic Variation in Radiologist Capacity and Widespread Implementation of Lung Cancer CT Screening. J Med Screen 21(4):207-15, 2014. e-Pub 2014. PMID: 25118160.
103. Ridner SH, Shih YCT, Doersam JK, Rhoten BA, Schultze BS, Dietrich MS. A Pilot Randomized Trial Evaluating Lymphedema Self-Measurement with Bioelectrical Impedance, Self-Care Adherence, and Health Outcomes. Lymphat Res Biol 12(4):258-66, 2014. e-Pub 2014. PMID: 25412401.
104. Jagsi R, Bekelman JE, Chen A, Chen RC, Hoffman K, Shih YCT, Smith BD, Yu JB. Considerations for observational research using large data sets in radiation oncology. Int J Radiat Oncol Biol Phys 90(1):11-24, 2014. PMID: 25195986.
105. Wang J, Qiao Y, Shih YCT, Wan JY, White-Means SI, Dagogo-Jack S, Cushman WC. Effects of Medicare Part D on Disparity Implications of Medication Therapy Management Eligibility Criteria. American Health & Drug Benefits 7(6):346-58, 2014. PMID: 25558303.
106. Sehdev A, Shih YCT, Huo D, Vekhter B, Lyttle C, Polite B. The role of statins for primary prevention in non-elderly colorectal cancer patients. Anticancer Res 34(9):5043-50, 2014. PMID: 25202089.
107. Shen C, Shih YCT, Xu Y, Yao JC. Octreotide long-acting repeatable use among elderly patients with carcinoid syndrome and survival outcomes: a population-based analysis. Cancer 120(13):2039-49, 2014. e-Pub 2014. PMID: 24676892.
108. Geynisman DM, Chien CR, Smieliauskas F, Shen C, Shih YCT. Economic evaluation of therapeutic cancer vaccines and immunotherapy: A systematic review. Hum Vaccin Immunother 10(11). e-Pub 2014. PMID: 25483656.
109. Wang J, Qiao Y, Shih YCT, Spivey CA, Dagogo-Jack S, Wan JY, White-Means SI, Cushman WC, Chisholm-Burns MA. Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria. J Pharm Health Serv Res 5(2):109-118, 2014. PMID: 25045406.
110. Wang J, Qiao Y, Shih YCT, Wan JY, White-Means SI, Dagogo-Jack S, Cushman WC. Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria. Res Social Adm Pharm 10(1):106-25, 2014. e-Pub 2013. PMID: 23759673.
111. Shen C, Chien CR, Geynisman DM, Smieliauskas F, Shih YCT. A review of economic impact of targeted oral anticancer medications. Expert Rev Pharmacoecon Outcomes Res 14(1):45-69, 2014. e-Pub 2013. PMID: 24378038.
112. Shih YCT, Xu Y, Dong W, Smieliauskas F, Giordano S, Shen Y. First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer. Breast Cancer Res Treat 144(2):417-25, 2014. e-Pub 2014. PMID: 24557339.
113. Kaplan AL, Trinh QD, Sun M, Carter SC, Nguyen PL, Shih YCT, Marks LS, Hu JC. Testosterone replacement therapy following the diagnosis of prostate cancer: outcomes and utilization trends. J Sex Med 11(4):1063-70, 2014. e-Pub 2014. PMID: 24443943.
114. Smieliauskas F, Chien CR, Shen C, Geynisman DM, Shih YCT. Cost-effectiveness analyses of targeted oral anti-cancer drugs: a systematic review. Pharmacoeconomics 32(7):651-80, 2014. PMID: 24821281.
115. Carter SC, Lipsitz S, Shih YCT, Nguyen PL, Trinh QD, Hu JC. Population-based determinants of radical prostatectomy operative time. BJU Int 113(5b):E112-8, 2014. e-Pub 2014. PMID: 24053198.
116. Pan IW, Smith BD, Shih YCT. Factors contributing to underuse of radiation among younger women with breast cancer. J Natl Cancer Inst 106(1):djt340, 2014. e-Pub 2013. PMID: 24317177.
117. Wymer KM, Shih YCT, Plunkett BA. The cost-effectiveness of a trial of labor accrues with multiple subsequent vaginal deliveries. Am J Obstet Gynecol 211(1):56.e1-56.e12, 2014. e-Pub 2014. PMID: 24487008.
118. Guadagnolo BA, Liao KP, Giordano SH, Elting LS, Buchholz TA, Shih YCT. Increasing use of advanced radiation therapy technologies in the last 30 days of life among patients dying as a result of cancer in the United States. J Oncol Pract 10(4):e269-76, 2014. e-Pub 2014. PMID: 24756144.
119. De Souza JA, Santana IA, de Castro G, de Lima Lopes G, Shih YCT. Economic analyses in squamous cell carcinoma of the head and neck: a review of the literature from a clinical perspective. Int J Radiat Oncol Biol Phys 89(5):989-96, 2014. e-Pub 2014. PMID: 25035201.
120. Shih YCT, Mullins Daniel C, Drummond M. The role of economic evaluation in meeting IOM's recommendations on delivering high-quality cancer care. Value Health 17(5):497-500, 2014. e-Pub 2014. PMID: 25128042.
121. Hu JC, Gandaglia G, Karakiewicz PI, Nguyen PL, Trinh QD, Shih YCT, Abdollah F, Chamie K, Wright JL, Ganz PA, Sun M. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control. Eur Urol 66(4):666-72, 2014. e-Pub 2014. PMID: 24602934.
122. Ahern CH, Shih YCT, Dong W, Parmigiani G, Shen Y. Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk. Br J Cancer 111(8):1542-51, 2014. e-Pub 2014. PMID: 25137022.
123. Balogh EP, Bach PB, Eisenberg PD, Ganz PA, Green RJ, Gruman JC, Nass SJ, Newcomer LN, Ramsey SD, Schottinger JE, Shih YCT. Practice-Changing Strategies to Deliver Affordable, High-Quality Cancer Care: Summary of an Institute of Medicine Workshop. J Oncol Pract 9(6S):54s-59s, 2013. PMID: 29431037.
124. Chen J, Liu L, Zhang D, Shih YCT. A flexible model for the mean and variance functions, with application to medical cost data. Stat Med 32(24):4306-18, 2013. e-Pub 2013. PMID: 23670952.
125. Chien CR, Shih YCT. Use of personalized decision analysis in decision making for Palliative vs. surgical management of the oldest-old patients with localized skin cancer in a culturally sensitive environment: a case study of a 96-year-old male Taiwanese patient. J Pain Symptom Manage 45(4):792-7, 2013. e-Pub 2012. PMID: 22917709.
126. Mullins CD, Jain R, Weir MR, Franey CS, Shih YCT, Pradel FG, Bikov K, Bartlett ST. Benefits Improvement and Protection Act's impact on transplantation rates among elderly MEDICARE beneficiaries with end-stage renal disease. Transplantation 95(3):463-9, 2013. PMID: 23314351.
127. Guadagnolo BA, Liao KP, Elting L, Giordano S, Buchholz TA, Shih YCT. Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States. J Clin Oncol 31(1):80-7, 2013. e-Pub 2012. PMID: 23169520.
128. Wender R, Fontham ET, Barrera E, Colditz GA, Church TR, Ettinger DS, Etzioni R, Flowers CR, Gazelle GS, Kelsey DK, LaMonte SJ, Michaelson JS, Oeffinger KC, Shih YCT, Sullivan DC, Travis W, Walter L, Wolf AM, Brawley OW, Smith RA. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 63(2):107-17, 2013. e-Pub 2013. PMID: 23315954.
129. Munshi KD, Shih YCT, Brown LM, Dagogo-Jack S, Wan JY, Wang J. Disparity implications of the Medicare medication therapy management eligibility criteria: a literature review. Expert Rev Pharmacoecon Outcomes Res 13(2):201-16, 2013. PMID: 23570431.
130. Schulman KL, Berenson K, Shih YCT, Foley KA, Ganguli A, de Souza J, Yaghmour NA, Shteynshlyuger A. A checklist for ascertaining study cohorts in oncology health services research using secondary data: report of the ISPOR oncology good outcomes research practices working group. Value Health 16(4):655-69, 2013. e-Pub 2013. PMID: 23796301.
131. Ramsey SD, Sullivan SD, Reed SD, Shih YCT, Schaecher K, Dhanda R, Patt D, Pendergrass K, Walker M, Malin J, Schwartzberg L, Neumann K, Yu E, Ravelo A, Small A. Oncology comparative effectiveness research: a multistakeholder perspective on principles for conduct and reporting. Oncologist 18(6):760-7, 2013. e-Pub 2013. PMID: 23650020.
132. Stout NL, Weiss R, Feldman JL, Stewart BR, Armer JM, Cormier JN, Shih YCT. A Systematic Review of Care Delivery Models and Economic Analyses in Lymphedema: Health Policy Impact, 2004-2011. Lymphology(46):27-41, 2013.
133. Aschebrook-Kilfoy B, Schechter RB, Shih YCT, Kaplan EL, Chiu BC, Angelos P, Grogan RH. The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Biomarkers Prev 22(7):1252-9, 2013. e-Pub 2013. PMID: 23677575.
134. Kowalczyk KJ, Harbin AC, Choueiri TK, Hevelone ND, Lipsitz SR, Trinh QD, Shih YCT, Hu JC. Use of surveillance imaging following treatment of small renal masses. J Urol 190(5):1680-5, 2013. e-Pub 2013. PMID: 23764074.
135. Shih YCT, Ganz PA, Aberle D, Abernethy A, Bekelman J, Brawley O, Goodwin JS, Hu JC, Schrag D, Temel JS, Schnipper L. Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol 31(32):4151-7, 2013. e-Pub 2013. PMID: 24127450.
136. Huang KH, Carter SC, Shih YCT, Hu JC. Robotic and standard open radical prostatectomy: oncological and quality-of-life outcomes. J Comp Eff Res 2(3):293-9, 2013. PMID: 24236628.
137. Balogh E, Bach P, Eisenberg P, Ganz PA, Green R, Gruman J, Nass S, Newcomer L, Ramsey S, Schottinger J, Shih YCT. Practice-Changing Strategies to Deliver Patient-Center, Affordable Cancer Care: Summary of an IOM Workshop. Journal of Oncology Practice:54-59, 2013.
138. Guadagnolo BA, Xu Y, Zagars GK, Cormier JN, Pollock RE, Feig BW, Giordano S, Buchholz TA, Shih YCT. A population-based study of the quality of care in the diagnosis of large ( 5 cm) soft tissue sarcomas. Am J Clin Oncol 35(5):455-61, 2012. PMID: 21537147.
139. Albert JM, Pan IW, Shih YCT, Jiang J, Buchholz TA, Giordano SH, Smith BD. Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery. Cancer 118(19):4642-51, 2012. e-Pub 2012. PMID: 22890779.
140. Chien CR, Su SY, Cohen L, Lin HW, Lee RT, Shih YCT. Use of Chinese medicine among survivors of nasopharyngeal carcinoma in Taiwan: a population-based study. Integr Cancer Ther 11(3):221-31, 2012. e-Pub 2011. PMID: 21498473.
141. Albert JM, Liu DD, Shen Y, Pan IW, Shih YCT, Hoffman KE, Buchholz TA, Giordano SH, Smith BD. Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery. J Clin Oncol 30(23):2837-43, 2012. e-Pub 2012. PMID: 22734034.
142. Patel AR, Prasad SM, Shih YCT, Eggener SE. The association of the human development index with global kidney cancer incidence and mortality. J Urol 187(6):1978-83, 2012. e-Pub 2012. PMID: 22498216.
143. Conti RM, Rosenthal MB, Polite BN, Bach PB, Shih YCT. Infused chemotherapy use in the elderly after patent expiration. Am J Manag Care 18(5):e173-8, 2012. e-Pub 2012. PMID: 22694111.
144. Smith GL, Xu Y, Buchholz TA, Giordano SH, Jiang J, Shih YCT, Smith BD. Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA 307(17):1827-37, 2012. PMID: 22550197.
145. Chien CR, Shih YCT. Reconciling Cancer Care Costs Reported by Different Government Agencies in Taiwan: Why Costing Approach Matters?. Value Health Reg Issues 1(1):111-117, 2012. e-Pub 2012. PMID: 29702817.
146. Shih YCT, Tai-Seale M. Physicians' perception of demand-induced supply in the information age: a latent class model analysis. Health Econ 21(3):252-69, 2012. e-Pub 2011. PMID: 21280137.
147. Shih YCT, Ward JF, Pettaway CA, Xu Y, Matin SF, Davis JW, Thompson BP, Elting LS. Comparative effectiveness, cost, and utilization of radical prostatectomy among young men within managed care insurance plans. Value Health 15(2):367-75, 2012. e-Pub 2011. PMID: 22433769.
148. Chien CR, Pan IW, Tsai YW, Tsai T, Liang JA, Buchholz TA, Shih YCT. Radiation therapy after breast-conserving surgery: does hospital surgical volume matter? A population-based study in Taiwan. Int J Radiat Oncol Biol Phys 82(1):43-50, 2012. e-Pub 2010. PMID: 21075558.
149. IW Pan, Chien CR, Shih YCT. Development of the TCDB-NHIRD Linked Database: What Can We Learn from the SEER-Medicare Database in the United States?. Taiwan Journal of Public Health (in Chinese) 31(4):299-310, 2012.
150. Chien CR, Shih YCT. Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC). Clinicoecon Outcomes Res 4:201-8, 2012. e-Pub 2012. PMID: 22870040.
151. Chavez-MacGregor M, Zhao H, Kroll M, Fang S, Zhang N, Hortobagyi GN, Buchholz TA, Shih YCT, Giordano SH. Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer. Ann Oncol 22(11):2394-402, 2011. e-Pub 2011. PMID: 21393379.
152. Shirvani SM, Pan IW, Buchholz TA, Shih YCT, Hoffman KE, Giordano SH, Smith BD. Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women. Cancer 117(20):4595-605, 2011. e-Pub 2011. PMID: 21710653.
153. Whitley E, Valverde P, Wells K, Williams L, Teschner T, Shih YCT. Establishing common cost measures to evaluate the economic value of patient navigation programs. Cancer 117(15 Suppl):3618-25, 2011. PMID: 21780096.
154. Smith BD, Pan IW, Shih YCT, Smith GL, Harris JR, Punglia R, Pierce LJ, Jagsi R, Hayman JA, Giordano SH, Buchholz TA. Adoption of intensity-modulated radiation therapy for breast cancer in the United States. J Natl Cancer Inst 103(10):798-809, 2011. e-Pub 2011. PMID: 21525437.
155. Shih YCT, Chien CR, Xu Y, Pan IW, Smith GL, Buchholz TA. Economic burden of renal cell carcinoma in the US: Part II--an updated analysis. Pharmacoeconomics 29(4):331-41, 2011. PMID: 21395352.
156. Shih YCT, Chien CR, Xu Y, Pan IW, Smith GL, Buchholz TA. Economic burden of renal cell carcinoma in the US: Part I--an updated review. Pharmacoeconomics 29(4):315-329, 2011. PMID: 21395351.
157. Cutler C, Kesselheim A, Gabardi Steven, Andersson BS, Carpenter P, Khoury HJ, Litzow M, Rowley SD, Lanum S, Leather H, Shih YCT, Gale RP, Wingard JR, Appelbaum FR, Anasetti C. Generic Immunosuppressants in Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 17(3):285-290, 2011. PMID: 21087678.
158. Smith GL, Xu Y, Buchholz TA, Smith BD, Giordano SH, Haffty BG, Vicini FA, White JR, Arthur DW, Harris JR, Shih YCT. Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care. J Clin Oncol 29(2):157-65, 2011. e-Pub 2010. PMID: 21135274.
159. Avritscher EB, Shih YCT, Sun CC, Gralla RJ, Grunberg SM, Xu Y, Elting LS. Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients. J Support Oncol 8(6):242-51, 2010. PMID: 21265391.
160. Wang J, Mullins CD, Brown LM, Shih YCT, Dagogo-Jack S, Hong SH, Cushman WC. Disparity implications of Medicare eligibility criteria for medication therapy management services. Health Serv Res 45(4):1061-82, 2010. e-Pub 2010. PMID: 20500223.
161. Smith GL, Shih YCT, Xu Y, Giordano SH, Smith BD, Perkins GH, Tereffe W, Woodward WA, Buchholz TA. Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study. Cancer 116(3):734-41, 2010. PMID: 20014181.
162. Shih YCT, Pan IW. Influenza Vaccination among Individuals with Cancer and Their Family Members. Am J Prev Med 38(1):61-9, 2010. PMID: 20117558.
163. Smith GL, Shih YCT, Giordano SH, Smith BD, Buchholz TA. A Method to Predict Breast Cancer Stage Using Medicare Claims. Epidemiol Perspect Innov 7:1, 2010. e-Pub 2010. PMID: 20145734.
164. Shih YCT, Elting LS, Pavluck AL, Stewart A, Halpern MT. Immunotherapy in the initial treatment of newly diagnosed cancer patients: utilization trend and cost projections for non-Hodgkin's lymphoma, metastatic breast cancer, and metastatic colorectal cancer. Cancer Invest 28(1):46-53, 2010. PMID: 19995227.
165. Wang J, Mullins CD, Chang CF, Gourley DR, Shih YCT, Cushman WC, Dagogo-Jack S, and White-Means SI. Comparisons of changes over time in per capita health expenditures across racial and ethnic groups. International Journal of Public Policy 6(3/4):172-89, 2010.
166. Xing Y, Cormier JN, Shih YCT, Kapadia AS, Swint JM, Askew RL, Pedroza C. Bayesian Bivariate Analysis applied to a Meta-analysis of Diagnostic Testing. Biostatistics, Bioinformatics, and 2(1):1-26, 2010.
167. Liu L, Strawderman RL, Cowen ME, Shih YCT. A flexible two-part random effects model for correlated medical costs. J Health Econ 29(1):110-23, 2010. e-Pub 2009. PMID: 20015560.
168. Smith GL, Xu Y, Shih YCT, Giordano SH, Smith BD, Hunt KK, Strom EA, Perkins GH, Hortobagyi GN, Buchholz TA. Breast-Conserving Surgery in Older Patients with Invasive Breast Cancer: Current Patterns of Treatment across the United States. J Am Coll Surg 209(4):425-33e2, 2009. e-Pub 2009. PMID: 19801315.
169. Shih YCT, Elting LS, Halpern MT. Factors associated with immunotherapy use among newly diagnosed cancer patients. Med Care 47(9):948-58, 2009. PMID: 19704352.
170. Elting LS, Cooksley CD, Bekele BN, Giordano SH, Shih YCT, Lovell KK, Avritscher EB, Theriault R. Mammography capacity impact on screening rates and breast cancer stage at diagnosis. Am J Prev Med 37(2):102-8, 2009. e-Pub 2009. PMID: 19524392.
171. Shih YCT, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, Perkins GH, Elting LS. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 27(12):2007-14, 2009. e-Pub 2009. PMID: 19289624.
172. Shih YCT, Pan IW, Tsai YW. Information Technology Facilitates Cost-Effectiveness Analysis in Developing Countries: An Observational Study of Breast Cancer Chemotherapy in Taiwan. Pharmacoeconomics 27(11):947-61, 2009. PMID: 19888794.
173. Shih YCT, Halpern MT. Economic evaluations of medical care interventions for cancer patients: how, why, and what does it mean?. CA Cancer J Clin 58(4):231-44, 2008. PMID: 18596196.
174. Jones JA, Qazilbash MH, Shih YCT, Cantor SB, Cooksley CD, Elting LS. In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample. Cancer 112(5):1096-105, 2008. PMID: 18286506.
175. Smith GL, Smith BD, Giordano SH, Shih YCT, Woodward WA, Strom EA, Perkins GH, Tereffe W, Yu TK, Buchholz TA. Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer 112(6):1371-9, 2008. PMID: 18213620.
176. Elting LS, Lu C, Escalante CP, Giordano SH, Trent JC, Cooksley C, Avritscher EB, Shih YCT, Ensor J, Bekele BN, Gralla RJ, Talcott JA, Rolston K. Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol 26(4):606-11, 2008. PMID: 18235119.
177. Shih YCT, Elting LS, Levin B. Disparities in Colorectal Screening Between US-Born and Foreign-Born Populations: Evidence from the 2000 National Health Interview Survey. J Cancer Educ 23(1):18-25, 2008. PMID: 18444042.
178. Shih YCT, Konrad TR. Factors Associated with the Income Distribution of Full-Time Physicians: A Quantile Regression Approach. Health Serv Res 42(5):1895-925, 2007. PMID: 17850525.
179. Shih YCT, Xu Y, Elting LS. Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy. Cancer 110(3):678-85, 2007. PMID: 17567835.
180. Du XL, Fang S, Vernon SW, El-Serag H, Shih YCT, Davila J, Rasmus ML. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer 110(3):660-9, 2007. PMID: 17582625.
181. Elting LS, Shih YCT, Stiff PJ, Bensinger W, Cantor SB, Cooksley C, Spielberger R, Emmanoulides C. Economic Impact of Palifermin on the Costs of Hospitalization for Autologous Hematopoietic Stem-Cell Transplant: Analysis of Phase 3 Trial Results. Biol Blood Marrow Transplant 13(7):806-13, 2007. e-Pub 2007. PMID: 17580258.
182. Shih YCT, Mauskopf J, Borker R. A Cost-Effectiveness Analysis of First-line Controller Therapies for Persistent Asthma. Pharmacoeconomics 25(7):577-90, 2007. PMID: 17610338.
183. Zhang S, Shih YCT, Muller P. A Spatially-adjusted Bayesian Additive Regression Tree. Bayesian Analysis 3(20):611-34, 2007.
184. Shih YCT, Bekele NB, Xu Y. Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients. Pharmacoeconomics 25(10):843-62, 2007. PMID: 17887806.
185. Shih YCT, Wang XS, Cantor SB, Cleeland CS. The Association Between Symptom Burdens and Utility in Chinese Cancer Patients. Qual Life Res 15(8):1427-38, 2006. e-Pub 2006. PMID: 16791743.
186. Shih YCT, Zhao L, Elting LS. Does Medicare coverage of colonoscopy reduce racial/ethnic disparities in cancer screening among the elderly?. Health Aff (Millwood) 25(4):1153-62, 2006. PMID: 16835198.
187. Shih YCT, Pusztai L. Do pharmacogenomic tests provide value to policy makers?. Pharmacoeconomics 24(12):1173-7, 2006. PMID: 17129072.
188. Shih YCT, Guo A, Just PM, Mujais S. Impact of Initial Dialysis Modality and Modality Switches on Medicare Expenditures of End-Stage Renal Disease Patients. Kidney Int 68(1):319-29, 2005. PMID: 15954923.
189. Shih YCT, Han S, Cantor SB. Impact of Generic Entry on Cost-Effectiveness Analysis. Med Decis Making 25(1):71-80, 2005. PMID: 15673583.
190. Shih YCT, Sleath BL. Health care provider knowledge of drug formulary status in ambulatory care settings. Am J Health Syst Pharm 61(24):2657-63, 2004. PMID: 15646700.
191. Avritscher EB, Cantor SB, Shih YCT, Escalante CP, Rivera E, Elting LS. Cost-Minimization Analysis of Low-Molecular-Weight Heparin (Dalteparin) Compared to Unfractionated Heparin for Inpatient Treatment of Cancer Patients with Deep Venous Thrombosis. Support Care Cancer 12(7):531-6, 2004. e-Pub 2004. PMID: 14986076.
192. Elting LS, Shih YCT. The Economic Burden of Supportive Care of Cancer Patients. Support Care Cancer 12(4):219-226, 2004. e-Pub 2004. PMID: 14767748.
193. Prasad M, Wahlqvist P, Shikiar R, Shih YCT. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharmacoeconomics 22(4):225-44, 2004. PMID: 14974873.
194. Shih YCT, Hartzema AG, Tolleson-Rinehart S. Labor Costs Associated with Incontinence in Long-Term Care Facilities. Urology 62(3):442-6, 2003. PMID: 12946743.
195. Shih YCT. Bayesian Approach in Pharmacoeconomics: Relevance to Decision-Makers. Expert Rev Pharmacoecon Outcomes Res 3(3):237-50, 2003. PMID: 19807372.
196. Sleath B, Shih YCT. Sociological Influences on Antidepressant Prescribing. Soc Sci Med 56(6):1335-44, 2003. PMID: 12600369.
197. Merchant S, Mullins CD, Shih YCT. Factors associated with hospitalization costs for patients with community-acquired pneumonia. Clin Ther 25(2):593-610, 2003. PMID: 12749516.
198. Shih YCT, Barghout VE, Sandler RS, Jhingran P, Sasane M, Cook S, Gibbons DC, Halpern M. Resource Utilization Associated with Irritable Bowel Syndrome in the United States 1987-1997. Dig Dis Sci 47(8):1705-15, 2002. PMID: 12184519.
199. Shih YCT, Prasad M, Luce BR. The Effect of RX-to-OTC Switch of the Second Generation Antihistamines on Social Welfare: A Microeconomic Approach. Clin Ther 24(4):701-16, 2002. PMID: 12017413.
200. Frank L, Revicki DA, Sorensen SV, Shih YCT. Cost-Effectiveness of Selective Serotonin Reuptake Inhibitors in Depression: A Critical Review. CNS Drugs 51(1):59-83, 2001. PMID: 11465013.
201. Harrell FE, Jr, Shih YCT. Using Full Probability Models to Compute Probabilities of Actual Interest to Decision-Makers. International Journal of Technology Assessment in Health Care 17(1):17-26, 2001. PMID: 11329842.
202. Biddle AK, Shih YCT, Kwong WJ. Cost-Benefit Analysis of Sumatriptan Tablets Versus Usual Therapy for Treatment of Migraine. Pharmacotherapy 20(11):1356-64, 2000. PMID: 11079284.
203. Ouslander JG, Shih YCT, Malone-Lee J, Luber K. Overactive Bladder: Special Considerations in the Geriatric Population. American Journal of Managed Care - Supplement II 6(11):S599-606, 2000. PMID: 11183903.
204. Shih YCT. Trends in Full-Time Pharmacists' Labor Market Characteristics. Journal of the American Pharmaceutical Association 40(1):26-35, 2000. PMID: 10665246.
205. Shih YCT, Kauf TL. Reconciling Decision Models with the Real World: The Cost-Effectiveness of Erythropoietin for ESRD-Related Anemia. PharmacoEconomics 15(5):481-93, 1999. PMID: 10537965.
206. Kauf TL, Shih YCT. Use of Home Health Care by ESRD and Medicare Beneficiaries. Health Care Financ Rev 20(4):127-38, 1999. PMID: 11482118.
207. Shih YCT. Growth and Geographic Distribution of Selected Health Professions, 1971-1996. Journal of Allied Health 28(2):61-70, 1999. PMID: 10389049.
208. Shih YCT, TL Kauf, AK Biddle, KN Simpson. Incorporating Problem-Based Learning Concepts into a Lecture-Based Pharmacoeconomics Course. American Journal of Pharmaceutical Education 63(2):152-9, 1999.
209. Shih YCT. Effect of insurance on prescription drug use by ESRD beneficiaries. Health Care Financ Rev 20(3):39-54, 1999. PMID: 10558019.
210. Liang KY, Shih YCT. Bayesian Composite Forecasts: An Extension and A Clarification. Journal of Quantitative Economics 10(1):105-22, 1994.

Invited Articles

1. Shih YCT, Xu Y. Economic Burden of Lymphedema. LymphLink 29(1).

Other Articles

1. Jagsi R, Bekelman JE, Chen A, Chen RC, Hoffman K, Shih YCT, Smith BD, Yu JB In reply to Rusthoven and Kavanagh. Int J Radiat Oncol Biol Phys 91(3):680-1, 2015. PMID: 25680609.
2. Shih YCT, Hurria A Preparing for an epidemic: cancer care in an aging population. Am Soc Clin Oncol Educ Book:133-7, 2014. PMID: 24857069.
3. McDougall JA, Ramsey SD, Shih YCT Financial Toxicity: A Growing Concern among Cancer Patients in the United States. ISPOR Connections, 2014.
4. Halpern MT, Shih YCT Patient Costs among Individuals with Cancer. Conference Proceeding of the 13th Annual International Conference on Industrial Engineering Theory, Applications & Practice, 2008.
5. Shih YCT Economic of Cancer in the Elderly Population. Workshop Proceeding.The National Academies Press, 2007.
6. Han S, Shih YCT A Dynamic Model of Budget Impact Analysis. 2004 ASA Proceedings:73-9, 2004.
7. Shih YCT, Sorensen S The Papanicolaou (Pap) Test Versus the PapSure Test for Cervical Cancer Screening: A Cost-Effectiveness Model in The Future of Cervical Cancer Diagnostics. Managed Care Consultant 2(4):18-23, 2002.

Editorials

1. Pan IW, Shih YCT. Invited Commentary on “Annual Medical Expenditure and Productivity Loss among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States.” Breast Diseases: A Year Book Quarterly 4(27):321-323, 2017.
2. Smith TJ, Shih YCT, Kelly RJ, Hillner BE. Value in Cancer Care, A Provider Perspective. ASCO Annual Meeting Daily News, 2014.
3. Shih YCT, Chien CR, Shen Y. Invited Commentary on “Cost Effectiveness of Fracture Prevention in Postmenopausal Women Who Receive Aromatase Inhibitors for Early Breast Cancer.” Breast Diseases: A Year Book Quarterly 24(1):18-23, 2013.
4. Davis JW, Shih YCT. Trends in the care of radical prostatectomy in the United States from 2003 to 2006. BJU Int 108(1):55, 2011. PMID: 21676146.
5. Xing Y, Shih YCT. Commentary on “Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts” Breast Diseases: A Year Book Quarterly 21(2):129-30, 2010.
6. Shih YCT, Fingeret MC, Reece GP. Commentary on "How Should Quality-of-Life Data Be Incorporated into a Cost Analysis of Breast Reconstruction? A Consideration of Implant versus Free TRAM Flap Procedures. Breast Diseases Quarterly 19(4):305-6, 2009.
7. Luce BR, Shih YCT, Claxton K. Introduction. Bayesian approaches to technology assessment and decision making. Int J Technol Assess Health Care 17(1):1-5, 2001. PMID: 11329837.

Book Chapters

1. Armer J, Feldman J, Ostby PL, Chance-Heltzler J, Sun YA, Armer NC, Shih YCT. Lymphedema within the Health Care System: Complexities, Economics, and Outcomes. In: Lymphedema: A Concise Compendium of Theory and Practice. 2^nd. Springer-Verlag: London, 503-523, 2018.
2. Liu L, Shih YCT, Henderson MF. Innovative Analytical Methods for Longitudinal Medical Cost Data: Translating Research to Inform Policy and Practice. In: Health Care Costs: Policies, Economics and Outcomes. Nova Science Publishers, Inc: Hauppauge, NY, 1-32, 2016.
3. Shih YCT, Smith BD. Economic Cost of Treating Older Adults with Cancer. In: Cancer and Aging: Research and Practice. Wiley-Blackwell Publisher: Hoboken, New Jersey, 2012.
4. Shih YCT. Deterministic analysis. In: Encyclopedia of Medical Decision Making. Sage Publications: Thousand Oaks, CA, 2009.
5. Hsieh CR, Lo KTV , Hong Y, Shih YCT. Pharmaceutical Innovation and Health Outcomes: Empirical Evidence from Taiwan. In: Pharmaceutical Innovations: Incentives, Competition, and Cost-Benefit Analysis in International Perspective. Cambridge Univeristy Press: New York, NY, 242-61, 2007.
6. Shih YCT. Cost Shifting or Sample Selection: the Case Study of Workers Compensation Back Pain Patients. In: Economics of Health Care in Asia-Pacific Countries. Edward Elgar Publishing: Cheltenham, UK, 193-212, 2002.